NEOS Investment Management LLC Purchases 4,284 Shares of Humana Inc. $HUM

NEOS Investment Management LLC raised its holdings in Humana Inc. (NYSE:HUM) by 49.1% in the 3rd quarter, Holdings Channel.com reports. The firm owned 13,017 shares of the insurance provider’s stock after acquiring an additional 4,284 shares during the period. NEOS Investment Management LLC’s holdings in Humana were worth $3,387,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. Rothschild Investment LLC boosted its holdings in Humana by 256.4% in the 3rd quarter. Rothschild Investment LLC now owns 499 shares of the insurance provider’s stock worth $130,000 after buying an additional 359 shares during the period. Fifth Third Bancorp raised its holdings in Humana by 16.6% during the 3rd quarter. Fifth Third Bancorp now owns 11,392 shares of the insurance provider’s stock valued at $2,964,000 after acquiring an additional 1,624 shares during the period. State of New Jersey Common Pension Fund D lifted its position in shares of Humana by 2.8% during the third quarter. State of New Jersey Common Pension Fund D now owns 42,122 shares of the insurance provider’s stock worth $10,959,000 after acquiring an additional 1,130 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Humana by 3.2% in the third quarter. PNC Financial Services Group Inc. now owns 79,223 shares of the insurance provider’s stock worth $20,611,000 after acquiring an additional 2,480 shares during the period. Finally, HighTower Advisors LLC grew its position in shares of Humana by 10.3% in the third quarter. HighTower Advisors LLC now owns 7,388 shares of the insurance provider’s stock valued at $1,922,000 after purchasing an additional 692 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Barclays restated an “underperformer” rating on shares of Humana in a research report on Monday, January 5th. JPMorgan Chase & Co. reduced their price objective on Humana from $274.00 to $180.00 and set a “neutral” rating on the stock in a research report on Friday, February 13th. Truist Financial reduced their price target on shares of Humana from $285.00 to $200.00 and set a “hold” rating on the stock in a research report on Tuesday. Wolfe Research lifted their target price on shares of Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research report on Thursday, January 8th. Finally, The Goldman Sachs Group cut their price target on shares of Humana from $215.00 to $158.00 and set a “sell” rating on the stock in a report on Friday, February 13th. Seven research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, Humana has a consensus rating of “Hold” and an average target price of $228.48.

Humana Stock Performance

Shares of HUM stock opened at $190.61 on Friday. The company has a quick ratio of 2.02, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The company has a 50 day moving average price of $239.01 and a 200-day moving average price of $259.13. Humana Inc. has a 52 week low of $169.61 and a 52 week high of $315.35. The firm has a market capitalization of $22.92 billion, a PE ratio of 19.41, a P/E/G ratio of 2.00 and a beta of 0.44.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. During the same quarter last year, the company posted ($2.16) earnings per share. The firm’s quarterly revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Friday, March 27th. Humana’s dividend payout ratio is 36.05%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.